Pharmacogenetics of the Human MDR1 Multidrug Transporter
Journal:
Current Pharmacogenomics
Volume:
2
Page:
1-11
Author(s):
Caroline G. Lee, Samuel S. Chong and Edmund J. D.Lee
Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)
Journal:
Current Pharmacogenomics
Volume:
2
Page:
75-82
Author(s):
R. M. Phillips and S. Basu
Thymidine Phosphorylase and Fluoropyrimidines Efficacy: A Jekyl and Hyde Story
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
71-81
Author(s):
Joseph Ciccolini, Alexandre Evrard and Pierre Cuq
Recent Anticancer Cytotoxic Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
93-121
Author(s):
Paolo Cozzi, Nicola Mongelli and Antonino Suarato
Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
123-138
Author(s):
Patrizia Russo, Maura Loprevite, Alfredo Cesario and Andrea Ardizzoni
Novel Non-Steroidal Anti-Inflammatory Drugs: What we have Learned from Animal Studies
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
43-61
Author(s):
G. Coruzzi, A. Menozzi and G. Dobrilla
Cyclooxygenase Enzymes: Regulation and Function
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
577-588
Author(s):
F. A. Fitzpatrick
Cancer and Cyclooxygenase-2 (COX-2) Inhibition
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
627-634
Author(s):
J. F. Evans and S. L.. Kargman
Dysregulated Post-Transcriptional Control of COX-2 Gene Expression in Cancer
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
635-646
Author(s):
Dan A. Dixon
Cyclooxygenase-2: Potential Role in Regulation of Drug Efflux and Multidrug Resistance Phenotype
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
647-657
Author(s):
A. Sorokin